Incidence And Time Course Of Adverse Events (Aes) With Atezolizumab (A) In Combination With Vemurafenib (V) And Cobimetinib (C) In The Phase Iii Imspire150 Study
Annals of Oncology(2020)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Annals of Oncology(2020)